InvestorsHub Logo
Followers 16
Posts 929
Boards Moderated 0
Alias Born 04/09/2015

Re: None

Thursday, 03/04/2021 9:07:04 AM

Thursday, March 04, 2021 9:07:04 AM

Post# of 462060
No kidding I hope - "This study is recruiting until 1 April 2021."

"Researchers are looking into a new potential drug, Blarcamesine which may be effective in the early stages of the disease.

The study is open to men and women aged between 60-85 who have a diagnosis of MCI or mild-stage Alzheimer’s disease.

Participants need to be either outpatients or residents of an assisted living facility and have a carer who spends at least 10 hours per week with them.

This is a Phase 3 trial which is recruiting across England and Scotland.

Within the first four weeks blood tests, physical examinations, memory tests and questionnaires will be used to determine if a participant can take part."


https://news.joindementiaresearch.nihr.ac.uk/new-potential-treatment-for-early-stage-alzheimers-disease/

They said "You should be on the stage!" (As in - the next stage out of town)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News